Zobrazeno 1 - 10
of 341
pro vyhledávání: '"Victor M, Rivera"'
Autor:
Fernando Gracia, Deyanira A. Ramírez Navarro, Nicia E. Ramírez Sánchez, Roberto Weiser, Alexander Parajeles-Vindas, Ligia I. Portillo Rivera, Ericka López Torres, Luis A. García Valle, Alfredo Sanabria-Castro, César Abdón López, Pahola Araujo, Maria J. Ayerdis Zamora, Andrea Balmaceda-Meza, Aron Benzadon Cohen, Awilda Candelario Cueto, Diego Castillo, Romy Castro-Escobar, Karla Z. Corea Urbina, Anyeri de Peña Rivas, Octavio Duarte Sotelo, Temís Enamorado Claros, José L. Giroud Benítez, Karla Gracia, Mario Larreategui, Jorge A. Martínez Cerrato, Josmarlin P. Medina Báez, Carlos E. Menjivar Samayoa, Gustavo Miranda-Loria, Priscilla Monterrey-Alvarez, Lilliam A. Morales Arguello, Michelle Ortiz, Carlos D. Pérez Baldioceda, Lizeth Pinilla Aguilar, Luis C. Rodríguez Salinas, Virginia Rodríguez-Moreno, Sebastián Rojas-Chaves, Norbel Román-Garita, Biany Santos Pujols, Carlos Valderrama, Ivonne Van Sijtveld, Indhira Zabala Angeles, Victor M. Rivera, Blas Armien
Publikováno v:
Frontiers in Epidemiology, Vol 4 (2024)
BackgroundMultiple Sclerosis (MS) is a common neurological disease among white populations of European origin. Frequencies among Latin Americans continue to be studied, however, epidemiologic, and clinical characterization studies lack from Central A
Externí odkaz:
https://doaj.org/article/fac4be136d2d4b2e88a54e71d870eade
Publikováno v:
Neurology and Therapy, Vol 12, Iss 1, Pp 319-327 (2022)
Abstract Background and Objectives Acute COVID-19 infection has been associated with neurological involvement. We report a case series of newly diagnosed patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) develop
Externí odkaz:
https://doaj.org/article/0f5052ee2d0b402fb7780a13a4d31679
Autor:
Fernando Gracia, Deyanira Ramírez, Alexander Parajeles-Vindas, Alejandro Díaz, Amado Díaz de la Fé, Nicia Eunice Ramírez Sánchez, Romy Castro Escobar, Luis Alberto García Valle, Roberto Weiser, Biany Santos, Awilda Candelario, Aron Benzadon, Pahola Araujo, Carlos Valderrama, Mario Larreategui, Gabriela Carrillo, Karla Gracia, Johana Vázquez-Céspedes, Priscilla Monterrey-Alvarez, Kenneth Carazo-Céspedes, Alfredo Sanabria-Castro, Gustavo Miranda-Loria, Andrea Balmaceda-Meza, Ligia Ibeth Portillo Rivera, Irma Olivera Leal, Luis Cesar Rodriguez Salinas, Arnold Thompson, Ericka López Torres, Daniel Enrique Pereira, Carolina Zepeda, César Abdón López, Ernesto Arturo Cornejo Valse, Karla Zinica Corea Urbina, Marco Antonio Urrutia, Ivonne Van Sijtveld, Blas Armien, Victor M. Rivera
Publikováno v:
Neurology International, Vol 14, Iss 1, Pp 284-293 (2022)
Here, a study of NMOSD in Central America and the Caribbean with a multinational collaborative, multicentric and descriptive approach involving 25 institutions from 9 countries is presented. Demographics, clinical manifestations, expanded disability
Externí odkaz:
https://doaj.org/article/0df03924ea45445587d9333661897939
Autor:
Victor M. Rivera
Publikováno v:
Journal of Integrative Neuroscience, Vol 22, Iss 6, p 139 (2023)
Externí odkaz:
https://doaj.org/article/47ac3012237f4d3f9715cc8088a2a62a
Publikováno v:
Neurology and Therapy, Vol 12, Iss 2, Pp 701-701 (2023)
Externí odkaz:
https://doaj.org/article/0432c3e2c3304fc3bf2e0e1455a9a705
Autor:
Victor M. Rivera
Publikováno v:
Neurology and Therapy, Vol 8, Iss 2, Pp 177-184 (2019)
Abstract Multiple sclerosis (MS) more than any other neurological disorder has experienced a tremendous progress in available evidence-based innovator disease modifying therapies (DMT). These medications include injectable complex nonbiological drugs
Externí odkaz:
https://doaj.org/article/6197b8900a054ffb87284cc705583fbb
Autor:
Victor M. Rivera
Publikováno v:
Biomedicines, Vol 9, Iss 11, p 1605 (2021)
The special issue on Multiple Sclerosis: Diagnosis and Treatment II, reflects advances and discoveries in the molecular and cellular mechanisms of disease, and novel laboratory techniques providing more sensitivity to diagnostic techninques and the u
Externí odkaz:
https://doaj.org/article/f13e262a3a3c4f5cb9ce136b14313a7a
Autor:
Alejandro Suárez-Méndez, Julio C. López-Curiel, Gustavo A. Fuentes, Benito Serrano-Rosales, Epifanio Morales-Zárate, Victor M. Rivera
Publikováno v:
Topics in Catalysis. 65:1218-1224
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf243ed9b114e402b3205616b8659dcd
https://doi.org/10.1007/s11244-022-01654-x
https://doi.org/10.1007/s11244-022-01654-x
Autor:
Victor M. Rivera, Tim Clackson, Frank Wang, William C. Shakespeare, Narayana I. Narasimhan, Qurish K. Mohemmad, Scott Wardwell, Lauren Moran, Matthew J. Wong, Joseph M. Gozgit
Members of the fibroblast growth factor receptor family of kinases (FGFR1–4) are dysregulated in multiple cancers. Ponatinib (AP24534) is an oral multitargeted tyrosine kinase inhibitor being explored in a pivotal phase II trial in patients with ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f39a803ac9fd251dac4bfc2513c8a34
https://doi.org/10.1158/1535-7163.c.6536118
https://doi.org/10.1158/1535-7163.c.6536118
Autor:
Tim Clackson, Frank Wang, John D. Iuliucci, Narayana I. Narasimhan, Roy Pollock, Yaoyu Ning, Scott D. Wardwell, Lori Berk, David Miller, Rachel M. Squillace, Victor M. Rivera
Supplementary Figure 3 from Ridaforolimus (AP23573; MK-8669), a Potent mTOR Inhibitor, Has Broad Antitumor Activity and Can Be Optimally Administered Using Intermittent Dosing Regimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a55a658107edbacb04f85646bc213606
https://doi.org/10.1158/1535-7163.22496250.v1
https://doi.org/10.1158/1535-7163.22496250.v1